Skip to content

FHP: what changed

What changed

FHP

BE 0762.693.578
NACE 86.910, Medical imaging and medical laboratories
filed annual accounts (NBB)
Financial years compared with
Net result for the year
-€93,339
2024 · -€396,255+€302,916
Equity
€768,563
2024 · €361,902+€406,661
Cash
€769,534
2024 · €374,488+€395,046
Balance sheet total
€773,222
2024 · €388,159+€385,063

Largest movements

2024 to 2025
Assets
  • Cash +€395,046

    up €395,046 (+105%), from €374,488 to €769,534

    mainly Contributions, distributions and other (+€500,000) and Receivables within one year (+€9,983)

  • Receivables within one year -€9,983

    down €9,983 (-73.0%), from €13,671 to €3,688

Equity and liabilities
  • Contributions +€500,000

    up €500,000 (+16.1%), from €3.1m to €3.6m

  • Profit (loss) carried forward -€93,339

    down €93,339 (-3.4%), from -€2.7m to -€2.8m

  • Trade debts -€21,599

    down €21,599 (-82.3%), from €26,257 to €4,659

Income statement
  • Gross operating margin +€304,229

    up €304,229 (+76.9%), from -€395,705 to -€91,475

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€396,255
Gross operating margin +€304,229
Other operating charges -€1,383
Financial charges +€70
Result 2025 -€93,339
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€104,954
Investment €0
Financing +€500,000
Cash 2024 €374,488
Net result for the year -€93,339
Receivables within one year +€9,983
Trade debts -€21,599
Contributions, distributions and other +€500,000
Cash 2025 €769,534
brings cash intakes cash out
Every line side by side 21 lines
Line Code 2024 2025 Change %
Total assets 20/58 €388,159 €773,222 +€385,063 +99.2%
Current assets 29/58 €388,159 €773,222 +€385,063 +99.2%
Amounts receivable within one year 40/41 €13,671 €3,688 -€9,983 -73.0%
Other amounts receivable 41 €13,671 €3,688 -€9,983 -73.0%
Cash at bank and in hand 54/58 €374,488 €769,534 +€395,046 +105%
Total equity and liabilities 10/49 €388,159 €773,222 +€385,063 +99.2%
Equity 10/15 €361,902 €768,563 +€406,661 +112%
Contributions 10/11 €3,103,000 €3,603,000 +€500,000 +16.1%
Profit (loss) carried forward 14 -€2,741,098 -€2,834,437 -€93,339 -3.4%
Amounts payable 17/49 €26,257 €4,659 -€21,599 -82.3%
Amounts payable within one year 42/48 €26,257 €4,659 -€21,599 -82.3%
Trade debts 44 €26,257 €4,659 -€21,599 -82.3%
Suppliers 440/4 €26,257 €4,659 -€21,599 -82.3%
Other operating charges 640/8 €118 €1,501 +€1,383 +1,172%
Gross operating margin 9900 -€395,705 -€91,475 +€304,229 +76.9%
Operating profit (loss) 9901 -€395,823 -€92,976 +€302,846 +76.5%
Financial charges 65/66B €432 €362 -€70 -16.1%
Recurring financial charges 65 €432 €362 -€70 -16.1%
Profit (loss) for the period before taxes 9903 -€396,255 -€93,339 +€302,916 +76.4%
Profit (loss) for the period 9904 -€396,255 -€93,339 +€302,916 +76.4%
Profit (loss) for the period to be appropriated 9905 -€396,255 -€93,339 +€302,916 +76.4%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.